Fairway, Kansas Clinical Trials

A listing of Fairway, Kansas clinical trials actively recruiting patient volunteers.

Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 10 clinical trials
Cookie Testing  

Cookie Testing

Online studies
Site
(online study)
  • 0 views
  • 19 Feb, 2024
  • 1 location
  • Online study
RJ_StudyVirtualF  

Acne

Online studies
Site1_RJ_StudyVirtual1N
(online study)
  • 0 views
  • 19 Feb, 2024
  • 1 location
  • Online study
T2

we

Online studies
8260013
(online study) Contact site
  • 0 views
  • 19 Feb, 2024
  • 1 location
  • Online study
A Study of CAD106 and CNP520 Versus Placebo in Participants at Risk for the Onset of Clinical Symptoms of Alzheimer's Disease

The purpose of this study is to test whether two investigational drugs called CAD106 and CNP520, administered separately, can slow down the onset and progression of clinical symptoms associated with Alzheimer's disease (AD) in participants at the risk to develop clinical symptoms based on their age and genotype.

mental state examination
apolipoprotein e4
Accepts healthy volunteers
alzheimer's disease
mini-mental state examination
Memory Disorders Program, Department of Neurological Sciences, University of Nebraska Medical Center
 (169.3 away) Contact site
  • 32 views
  • 20 Sep, 2024
  • +126 other locations
A Medical Research Study Designed to Determine if Venglustat Can be a Future Treatment for ADPKD Patients

Primary Objective: To determine the effect of venglustat on the rate of total kidney volume (TKV) growth (Stage and estimated glomerular filtration rate (eGFR) decline in patients at risk of rapidly progressive Autosomal Dominant Polycystic Kidney Disease (ADPKD) (Stage 2). Secondary Objectives: To determine the effect of venglustat on the …

depression
human chorionic gonadotropin
fatigue
glomerular filtration rate
treatment regimen
Investigational Site Number 8400003
 (2.4 away) Contact site
  • 0 views
  • 19 Feb, 2024
  • +80 other locations
Phase 2 Study of SAR439859 Versus Physician's Choice in Locally Advanced or Metastatic ER-positive Breast Cancer (AMEERA-3)

Primary Objective: To determine whether SAR439859 per os improves progression free survival (PFS) when compared with a endocrine monotherapy of the choice of the physician, in participants with metastatic or locally advanced breast cancer. Secondary Objectives: To compare the overall survival in the 2 treatment arms To assess the objective …

er-positive breast cancer
hormone therapy
cancer
estrogen receptor positive breast cancer
advanced breast cancer
Investigational Site Number 8400032
 (3.1 away) Contact site
  • 0 views
  • 19 Feb, 2024
  • +125 other locations
International Collaborative Gaucher Group (ICGG) Gaucher Disease Registry & Pregnancy Sub-registry

The ICGG Gaucher Registry is an ongoing, international multi-center, strictly observational program that tracks the routine clinical outcomes for patients with Gaucher disease, irrespective of treatment status. No experimental intervention is involved; patients in the Registry undergo clinical assessments and receive care as determined by the patient's treating physician. The …

eliglustat
gaucher disease
imiglucerase
deficiency
Investigational Site Number 840063
 (4.3 away) Contact site
  • 0 views
  • 19 Feb, 2024
  • +208 other locations
Pompe Disease Registry

The Pompe Registry is an ongoing, international multi-center, strictly observational program that tracks the routine clinical outcomes for patients with Pompe disease, irrespective of treatment status. No experimental intervention is involved; patients in the Registry undergo clinical assessments and receive care as determined by the patient's treating physician. The objectives …

replacement therapy
gaa gene
deficiency
glycogen storage disease type ii
myozyme
Investigational Site Number 840020
 (2.9 away) Contact site
  • 0 views
  • 19 Feb, 2024
  • +168 other locations
Fabry Disease Registry & Pregnancy Sub-registry

The Fabry Registry is an ongoing, international multi-center, strictly observational program that tracks the routine clinical outcomes for patients with Fabry disease, irrespective of treatment status. No experimental intervention is involved; patients in the Registry undergo clinical assessments and receive care as determined by the patient's treating physician. The primary …

agalsidase beta
replacement therapy
fabrazyme
deficiency
fabry's disease
Investigational Site Number 840071
 (2.9 away) Contact site
  • 0 views
  • 05 Aug, 2024
  • +125 other locations
A Prospective Non-interventional Multinational Observational Study With Isatuximab in Patients With Relapsed and/or Refractory Multiple Myeloma (RRMM)

Primary Objective: To assess the effectiveness, in terms of overall response rate (ORR) of isatuximab patients with RRMM in routine clinical practice, within 12 months To assess other effectiveness parameters such as progression free survival (PFS), PFS rate (PFSR), duration of response (DoR), time to response, time and intent to …

multiple myeloma
cancer
carcinoma
refractory multiple myeloma
isatuximab
Investigational Site Number 8400016
 (5.0 away) Contact site
  • 0 views
  • 19 Feb, 2024
  • +9 other locations